PL2987793T3 - Heterocykliczny związek amidu kwasu octowego - Google Patents
Heterocykliczny związek amidu kwasu octowegoInfo
- Publication number
- PL2987793T3 PL2987793T3 PL14786115T PL14786115T PL2987793T3 PL 2987793 T3 PL2987793 T3 PL 2987793T3 PL 14786115 T PL14786115 T PL 14786115T PL 14786115 T PL14786115 T PL 14786115T PL 2987793 T3 PL2987793 T3 PL 2987793T3
- Authority
- PL
- Poland
- Prior art keywords
- acetic acid
- acid amide
- amide compound
- heterocyclic acetic
- heterocyclic
- Prior art date
Links
- -1 Heterocyclic acetic acid amide compound Chemical class 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Epidemiology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyrrole Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2013087151 | 2013-04-18 | ||
| PCT/JP2014/061007 WO2014171528A1 (ja) | 2013-04-18 | 2014-04-18 | ヘテロ環酢酸アミド化合物 |
| EP14786115.7A EP2987793B1 (en) | 2013-04-18 | 2014-04-18 | Heterocyclic acetic acid amide compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2987793T3 true PL2987793T3 (pl) | 2018-05-30 |
Family
ID=51729480
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL14786115T PL2987793T3 (pl) | 2013-04-18 | 2014-04-18 | Heterocykliczny związek amidu kwasu octowego |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US8937087B2 (pl) |
| EP (1) | EP2987793B1 (pl) |
| JP (1) | JP6252582B2 (pl) |
| KR (1) | KR102193247B1 (pl) |
| CN (1) | CN105121435B (pl) |
| AR (1) | AR095883A1 (pl) |
| AU (1) | AU2014254768B2 (pl) |
| BR (1) | BR112015026512B1 (pl) |
| CA (1) | CA2909783C (pl) |
| CY (1) | CY1119754T1 (pl) |
| DK (1) | DK2987793T3 (pl) |
| EA (1) | EA028968B1 (pl) |
| ES (1) | ES2651866T3 (pl) |
| HR (1) | HRP20171786T1 (pl) |
| HU (1) | HUE036054T2 (pl) |
| IL (1) | IL241962B (pl) |
| LT (1) | LT2987793T (pl) |
| ME (1) | ME02891B (pl) |
| MX (1) | MX2015014646A (pl) |
| MY (1) | MY175971A (pl) |
| NO (1) | NO2987793T3 (pl) |
| NZ (1) | NZ713118A (pl) |
| PH (1) | PH12015502341B1 (pl) |
| PL (1) | PL2987793T3 (pl) |
| PT (1) | PT2987793T (pl) |
| RS (1) | RS56865B1 (pl) |
| SA (1) | SA515370015B1 (pl) |
| SG (1) | SG11201508448RA (pl) |
| SI (1) | SI2987793T1 (pl) |
| SM (1) | SMT201700594T1 (pl) |
| TW (1) | TWI625329B (pl) |
| UA (1) | UA116243C2 (pl) |
| WO (1) | WO2014171528A1 (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR105025A1 (es) * | 2015-06-19 | 2017-08-30 | Astellas Pharma Inc | Compuesto de imidazodiazepina |
| TWI725408B (zh) | 2018-04-20 | 2021-04-21 | 美商美國禮來大藥廠 | 多巴胺d1受體正向異位調節劑 |
| BR112021003665A2 (pt) | 2018-09-13 | 2021-05-18 | Bayer Aktiengesellschaft | derivados de heterocicleno como agentes de controle de pragas |
| CN110590576A (zh) * | 2019-08-15 | 2019-12-20 | 安徽金禾实业股份有限公司 | 一种4-多氟代甲氧基邻苯二胺的制备方法 |
| CN114380709B (zh) * | 2021-12-31 | 2023-07-21 | 西北农林科技大学 | 4-氯-2-酰氨基酚的合成方法 |
Family Cites Families (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2674524B1 (fr) * | 1991-03-25 | 1993-05-21 | Adir | Nouveaux amides alkyl heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent. |
| US6627624B1 (en) | 1999-04-02 | 2003-09-30 | Neurogen Corporation | Aryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
| AU4058000A (en) * | 1999-04-02 | 2000-10-23 | Neurogen Corporation | Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulatorsof gabaa receptors |
| US6380210B1 (en) | 1999-04-02 | 2002-04-30 | Neurogen Corporation | Heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of GABAa receptors |
| AUPQ309399A0 (en) | 1999-09-28 | 1999-10-21 | Fujisawa Pharmaceutical Co., Ltd. | Benzothiazoline derivatives |
| DE60234616D1 (de) | 2001-09-14 | 2010-01-14 | High Point Pharmaceuticals Llc | Substituierte piperidinen mit selektiver bindungsfähigkeit zu histamin h3-rezeptoren |
| US7361671B2 (en) | 2001-11-15 | 2008-04-22 | The Institute For Pharmaceutical Discovery, Inc. | Substituted heteroarylalkanoic acids |
| NZ534757A (en) | 2002-03-12 | 2006-07-28 | Merck & Co Inc | Substituted amides |
| CA2519475A1 (en) | 2003-03-14 | 2004-09-30 | Merck & Co., Inc. | Bicyclic anilide spirohydantoin cgrp receptor antagonists |
| WO2005080334A1 (ja) | 2004-02-23 | 2005-09-01 | Dainippon Sumitomo Pharma Co., Ltd. | 新規へテロ環化合物 |
| WO2005118561A1 (en) | 2004-05-27 | 2005-12-15 | Ucb, S.A. | Benzoxazolone derivatives, processes for preparing them and their uses |
| US7790726B2 (en) | 2005-08-16 | 2010-09-07 | Chemocentryx, Inc. | Monocyclic and bicyclic compounds and methods of use |
| WO2007073432A2 (en) | 2005-10-11 | 2007-06-28 | Chemocentryx, Inc. | Piperidine derivatives and methods of use |
| CL2007002097A1 (es) * | 2006-07-20 | 2008-01-18 | Smithkline Beecham Corp | Compuestos derivados de pirrolidina o morfolina antagonistas de urotensina ii; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar insuficiencia cardiaca congestiva, insuficiencia cardiaca isquemica, angina, isquemia del miocardio, vejiga hiperactiva, asma y/o copd, entre otras. |
| US7786157B2 (en) | 2007-03-16 | 2010-08-31 | Chemocentryx, Inc. | OXO-imidazolidines as modulators of chemokine receptors |
| DE102007026341A1 (de) * | 2007-06-06 | 2008-12-11 | Merck Patent Gmbh | Benzoxazolonderivate |
| GB0713686D0 (en) * | 2007-07-13 | 2007-08-22 | Addex Pharmaceuticals Sa | New compounds 2 |
-
2014
- 2014-04-16 AR ARP140101624A patent/AR095883A1/es active IP Right Grant
- 2014-04-17 TW TW103114022A patent/TWI625329B/zh not_active IP Right Cessation
- 2014-04-18 ME MEP-2017-277A patent/ME02891B/me unknown
- 2014-04-18 ES ES14786115.7T patent/ES2651866T3/es active Active
- 2014-04-18 MX MX2015014646A patent/MX2015014646A/es active IP Right Grant
- 2014-04-18 BR BR112015026512-0A patent/BR112015026512B1/pt not_active IP Right Cessation
- 2014-04-18 PT PT147861157T patent/PT2987793T/pt unknown
- 2014-04-18 EA EA201591988A patent/EA028968B1/ru not_active IP Right Cessation
- 2014-04-18 CN CN201480020846.XA patent/CN105121435B/zh active Active
- 2014-04-18 HR HRP20171786TT patent/HRP20171786T1/hr unknown
- 2014-04-18 KR KR1020157027691A patent/KR102193247B1/ko not_active Expired - Fee Related
- 2014-04-18 HU HUE14786115A patent/HUE036054T2/hu unknown
- 2014-04-18 MY MYPI2015703694A patent/MY175971A/en unknown
- 2014-04-18 NO NO14786115A patent/NO2987793T3/no unknown
- 2014-04-18 SM SM20170594T patent/SMT201700594T1/it unknown
- 2014-04-18 NZ NZ713118A patent/NZ713118A/en not_active IP Right Cessation
- 2014-04-18 WO PCT/JP2014/061007 patent/WO2014171528A1/ja not_active Ceased
- 2014-04-18 LT LTEP14786115.7T patent/LT2987793T/lt unknown
- 2014-04-18 US US14/256,135 patent/US8937087B2/en active Active
- 2014-04-18 SG SG11201508448RA patent/SG11201508448RA/en unknown
- 2014-04-18 RS RS20171324A patent/RS56865B1/sr unknown
- 2014-04-18 JP JP2015512531A patent/JP6252582B2/ja active Active
- 2014-04-18 DK DK14786115.7T patent/DK2987793T3/en active
- 2014-04-18 SI SI201430479T patent/SI2987793T1/en unknown
- 2014-04-18 AU AU2014254768A patent/AU2014254768B2/en not_active Ceased
- 2014-04-18 EP EP14786115.7A patent/EP2987793B1/en active Active
- 2014-04-18 CA CA2909783A patent/CA2909783C/en active Active
- 2014-04-18 PL PL14786115T patent/PL2987793T3/pl unknown
- 2014-04-18 UA UAA201511337A patent/UA116243C2/uk unknown
- 2014-10-28 US US14/525,982 patent/US9708307B2/en active Active
-
2015
- 2015-10-07 IL IL241962A patent/IL241962B/en active IP Right Grant
- 2015-10-08 PH PH12015502341A patent/PH12015502341B1/en unknown
- 2015-10-18 SA SA515370015A patent/SA515370015B1/ar unknown
-
2017
- 2017-12-06 CY CY20171101288T patent/CY1119754T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3026051A4 (en) | Heterocyclic compound | |
| EP3029031A4 (en) | Heterocyclic compound | |
| EP3018123A4 (en) | Amide compound | |
| EP2832734A4 (en) | HETEROCYCLIC COMPOUND | |
| ZA201504980B (en) | Heterocyclic compound | |
| GB201311891D0 (en) | Novel compound | |
| SG11201600759XA (en) | Novel quinoline-substituted compound | |
| SG11201600473UA (en) | Amino acid derivatives | |
| IL245301A0 (en) | New heterocyclic compounds | |
| RU2016118399A3 (en) | 4-aminomethylbenzoic acid derivative | |
| IL245379A0 (en) | Heterocyclic n-acylamino compounds | |
| EP2975031A4 (en) | Heterocyclic compound | |
| EP3006444A4 (en) | HETEROCYCLIC AMID COMPOUND | |
| EP3061754A4 (en) | Heterocyclic compound | |
| SG11201508542SA (en) | Dicarboxylic acid compound | |
| SI3063139T1 (sl) | Heterociklična spojina | |
| HRP20181371T1 (hr) | Spoj estera gvanidinbenzojeve kiseline | |
| PL2987793T3 (pl) | Heterocykliczny związek amidu kwasu octowego | |
| ZA201601666B (en) | Heterocyclic amide compound and herbicide | |
| IL244347A0 (en) | n-acylamino heterocyclic compounds | |
| PL2943474T3 (pl) | Związki stanowiące pochodne cycloheksenu podstawionego biarylem lub heterocyklicznym biarylem jako inhibitory cetp | |
| SG10201401381SA (en) | Acid injection | |
| GB201314960D0 (en) | Heterocyclic derivatives | |
| GB201300306D0 (en) | Heterocyclic derivatives | |
| TH1401006870A (th) | สารประกอบคาร์บอกซิลิคแอซิด |